Outcomes of pregnancy in neuromyelitis optica patients: turkish multicenter study data
| dc.contributor.author | Altintas, A. | |
| dc.contributor.author | Uygunoglu, U. | |
| dc.contributor.author | Terzi, M. | |
| dc.contributor.author | Boz, C. | |
| dc.contributor.author | Saip, S. | |
| dc.contributor.author | Koseoglu, M. | |
| dc.contributor.author | Siva, A. | |
| dc.date.accessioned | 2026-08-12T18:12:52Z | |
| dc.date.issued | 2016 | |
| dc.department | Fırat Üniversitesi | |
| dc.description | 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -- SEP 14-17, 2016 -- London, ENGLAND | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.description.sponsorship | Teva; Merck Serono; Gen Ilac; Bayer Schering; Novartis; Sanofi Genzyme | |
| dc.description.sponsorship | A. Altintas: She received honoraria, research and travel grants from Teva, Merck Serono, Gen Ilac, Bayer Schering, NovartisA. Siva: He received honoraria, research and travel grants from Teva, Merck Serono, Gen Ilac, Bayer Schering, Novartis, Sanofi Genzyme | |
| dc.description.sponsorship | European Comm Treatment & Res Multiple Sclerosis | |
| dc.identifier.endpage | 406 | |
| dc.identifier.issn | 1352-4585 | |
| dc.identifier.issn | 1477-0970 | |
| dc.identifier.startpage | 405 | |
| dc.identifier.uri | https://hdl.handle.net/11508/64083 | |
| dc.identifier.volume | 22 | |
| dc.identifier.wos | WOS:000383267202012 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | Sage Publications Ltd | |
| dc.relation.ispartof | Multiple Sclerosis Journal | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.title | Outcomes of pregnancy in neuromyelitis optica patients: turkish multicenter study data | |
| dc.type | Conference Object |







